BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.”Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- ...
D2B is a semi-automated process that allows fast biological assessment of crude reaction mixtures within a plate, shortening ...
Fujitsu Ltd, Mizuho Financial Group Inc, and drugmaker PeptiDream Inc said on Thursday they are forming a joint venture to develop treatments for COVID-19.
A logical approach to investigating a case of muscle ‘aches and pains’ to rule out serious pathology and reach a diagnosis ...
In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results